New therapy reduces chronic low back pain in large international study

(University of Rochester Medical Center) A new study has found that tanezumab, a monoclonal antibody that inhibits nerve activity, provides relief in patients with chronic low back pain, one of the leading reasons why people seek medical care and the number one cause of disability worldwide.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news